|
|
MarketView
Events defining the day's trading activity on Wall Street
Lauren Rudd
Tuesday, April 20, 2010
Summary Share prices were higher on Tuesday as oil prices
lifted energy stocks and Wall Street remained relatively upbeat over the
ongoing recovery in corporate profits, even as some high-profile
companies fell short of lofty expectations. Goldman Sachs earnings trounced forecasts, but its
share price fell 2.1 percent to $159.98 as UK regulators launched a
probe into alleged fraud by the company, thereby adding to worries
caused by fraud charges here in the United States. The broad market benefited from the view that
earnings are indicating beyond a doubt that the economy is recovering,
even though some of the big names that reported solid results, such as
UnitedHealth Group, ended the day lower. After the closing bell, the latest companies to
release earnings included Apple and Yahoo. Shares of Apple rose more
than 6 percent to $260.99, extending its record high in after-hours
trading. Apple reported results above expectations, led by strong sales
of the iPhone. Meanwhile, Yahoo gave up 1.9 percent to $18.03 in
extended trading after its earnings exceeded Street expectations but
revenues did not. During the regular session, more than four stocks
rose for every one that fell on the New York Stock Exchange, while on
the Nasdaq, three stocks rose for every decliner. Energy shares led the upside as oil rebounded when
some European flights resumed with the threat from Iceland's volcanic
ash cloud receding. Crude was up more than 2 percent at $83.45 per
barrel, though trade volumes for the May contract were low on the
contract's last day. IBM posted better-than-expected earnings but
disappointing gross margins. The stock eased back 1.9 percent to $129.69
and was largest drag on the Dow Jones industrial average, followed by
Coca-Cola, which fell 1.5 percent to $54.47. Coke reported mixed
results; Johnson & Johnson exceeded quarterly estimates but trimmed its
full-year profit forecast, while UnitedHealth soared past estimates.
Johnson & Johnson saw its share price fall 0.1 percent to $65.99 and
UnitedHealth was down 0.8 percent at $30.98.
Potential Fraud at Goldman Sachs Overshadows
Dramatic Earnings Increase
Goldman Sachs reported blow-out quarterly earnings on
Tuesday, but investors appeared to focus on the fraud case against the
bank as Britain's market watchdog launched its own probe. Goldman's
results, which failed to send its shares upward, came four days after
the Securities and Exchange Commission accused the dominant Wall Street
bank of defrauding investors by failing to say that a prominent hedge
fund manager bet against a Goldman subprime debt product that he helped
design. Goldman's troubles also caused political
reverberations. A top Republican congressman questioned whether politics
affected the timing of the government's case, while in Britain, the
Liberal Democrat party's leader said Goldman should be banned from UK
government contracts until the case is settled. Goldman reported that its first-quarter net income
nearly doubled to $3.29 billion, due in large part to the strength in
fixed income trading and principal investments. Earnings were $5.59 per
share. The bank also reported its lowest-ever first-quarter compensation
ratio, but it still set aside $5.5 billion for compensation and benefits
in the period. The reduction in money set aside served to bolster
earnings that could bring more public scrutiny to the 141-year old bank,
last year described as a "giant vampire squid wrapped around the face of
humanity" by Rolling Stone magazine. Goldman shares fell 2.05 percent to close at $159.98,
even as many other bank shares, including archrival Morgan Stanley,
rallied. Furthermore, the shares are down 19 percent over the past week. The bank's co-general counsel, Greg Palm, rebutted
the SEC charges during the bank's earnings conference call. Palm said
the firm was "very disappointed" that the SEC brought charges and said
Goldman "would never mislead anyone." He also said investors who lost
money on the subprime mortgage product that is the focus of the SEC suit
had a wealth of experience and background in such deals. Palm faced questions about Goldman's failure to alert
investors when it first received a "Wells Notice" from the SEC regarding
the agency's investigation. Palm insisted that Goldman would disclose
any investigation or inquiry that it considered material. "We do not
disclose every Wells Notice we get because that would not make sense,"
he said. Goldman's forecast-beating earnings came as Britain's
Financial Services Authority (FSA) said it had started a formal
investigation into Goldman Sachs International in relation to the SEC
allegations. FSA said it would work closely with its U.S. counterpart. Goldman was "distressed" by the wave of negative
publicity and said that most customers remain loyal, Chief Financial
Officer David Viniar said. "We are out talking to our clients," he told
analysts on the conference call. "You can see from our results last
quarter that our clients still support us." Some financial institutions are reviewing their
dealings with Goldman during the financial crisis to see if they have
any legal recourse. American International Group Inc took a loss of up
to $2 billion last year as it ended credit default swaps it had written
on some Goldman collateralized debt obligations. Meanwhile, Goldman has deregistered Fabrice Tourre
with the UK financial regulator, the bank said, given that the employee
at the center of the case is on paid leave and was therefore not
undertaking his registered activities. The bank said that it had concluded in an earlier
internal investigation that Tourre had done "nothing wrong." Political tensions were heightened by a split along
political lines among SEC commissioners last week in a vote on whether
to file suit against Goldman. A top Republican lawmaker is raising
questions about the SEC's fraud case against Goldman Sachs, implying
political motives -- a charge that the SEC denies. "The timing of the SEC's filing of a civil securities
fraud action against Goldman Sachs has created serious questions about
the commission's independence and impartiality," said Darrell Issa, the
top Republican on the House Oversight Committee, in a letter to the SEC
on Tuesday. Republicans have raised questions about the timing of
the case, filed on Friday just before the Senate was to start debating a
bill that would usher in new rules for Wall Street. SEC Chairman Mary Schapiro told reporters on Tuesday
that the agency's decision to charge Goldman was "absolutely not"
politically motivated.
|
|
|
MarketView for April 20
MarketView for Tuesday, April 20